2-238329110-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015650.4(TRAF3IP1):​c.683A>G​(p.Asn228Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0601 in 1,550,390 control chromosomes in the GnomAD database, including 5,130 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Synonymous variant affecting the same amino acid position (i.e. N228N) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.12 ( 1737 hom., cov: 31)
Exomes 𝑓: 0.054 ( 3393 hom. )

Consequence

TRAF3IP1
NM_015650.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.658

Publications

10 publications found
Variant links:
Genes affected
TRAF3IP1 (HGNC:17861): (TRAF3 interacting protein 1) The protein encoded by this gene interacts with TNF receptor-associated factor 3, tethering it to cytoskeletal microtubules. The encoded protein is also an inhibitor of the innate type I IFN response. Defects in this gene are a cause of Senior-Loken syndrome 9. [provided by RefSeq, Mar 2017]
TRAF3IP1 Gene-Disease associations (from GenCC):
  • Senior-Loken syndrome 9
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Senior-Loken syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • short rib-polydactyly syndrome, Majewski type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0046848953).
BP6
Variant 2-238329110-A-G is Benign according to our data. Variant chr2-238329110-A-G is described in ClinVar as Benign. ClinVar VariationId is 1167549.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.263 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRAF3IP1NM_015650.4 linkc.683A>G p.Asn228Ser missense_variant Exon 5 of 17 ENST00000373327.5 NP_056465.2 Q8TDR0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRAF3IP1ENST00000373327.5 linkc.683A>G p.Asn228Ser missense_variant Exon 5 of 17 1 NM_015650.4 ENSP00000362424.4 Q8TDR0-1
TRAF3IP1ENST00000391993.7 linkc.683A>G p.Asn228Ser missense_variant Exon 5 of 15 1 ENSP00000375851.3 Q8TDR0-2
TRAF3IP1ENST00000409739.2 linkn.*552A>G non_coding_transcript_exon_variant Exon 5 of 5 3 ENSP00000386648.2 H7BZ10
TRAF3IP1ENST00000409739.2 linkn.*552A>G 3_prime_UTR_variant Exon 5 of 5 3 ENSP00000386648.2 H7BZ10

Frequencies

GnomAD3 genomes
AF:
0.116
AC:
17578
AN:
151526
Hom.:
1732
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.267
Gnomad AMI
AF:
0.0285
Gnomad AMR
AF:
0.0814
Gnomad ASJ
AF:
0.0473
Gnomad EAS
AF:
0.103
Gnomad SAS
AF:
0.113
Gnomad FIN
AF:
0.113
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.0394
Gnomad OTH
AF:
0.0982
GnomAD2 exomes
AF:
0.0810
AC:
12466
AN:
153818
AF XY:
0.0782
show subpopulations
Gnomad AFR exome
AF:
0.270
Gnomad AMR exome
AF:
0.0759
Gnomad ASJ exome
AF:
0.0467
Gnomad EAS exome
AF:
0.108
Gnomad FIN exome
AF:
0.105
Gnomad NFE exome
AF:
0.0409
Gnomad OTH exome
AF:
0.0702
GnomAD4 exome
AF:
0.0541
AC:
75608
AN:
1398746
Hom.:
3393
Cov.:
31
AF XY:
0.0546
AC XY:
37684
AN XY:
690062
show subpopulations
African (AFR)
AF:
0.280
AC:
8795
AN:
31398
American (AMR)
AF:
0.0768
AC:
2722
AN:
35426
Ashkenazi Jewish (ASJ)
AF:
0.0451
AC:
1135
AN:
25142
East Asian (EAS)
AF:
0.112
AC:
3994
AN:
35738
South Asian (SAS)
AF:
0.0985
AC:
7802
AN:
79196
European-Finnish (FIN)
AF:
0.103
AC:
5089
AN:
49306
Middle Eastern (MID)
AF:
0.0991
AC:
559
AN:
5642
European-Non Finnish (NFE)
AF:
0.0386
AC:
41610
AN:
1078916
Other (OTH)
AF:
0.0673
AC:
3902
AN:
57982
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
4170
8339
12509
16678
20848
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1766
3532
5298
7064
8830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.116
AC:
17609
AN:
151644
Hom.:
1737
Cov.:
31
AF XY:
0.118
AC XY:
8773
AN XY:
74120
show subpopulations
African (AFR)
AF:
0.267
AC:
11019
AN:
41216
American (AMR)
AF:
0.0815
AC:
1243
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.0473
AC:
164
AN:
3468
East Asian (EAS)
AF:
0.102
AC:
526
AN:
5150
South Asian (SAS)
AF:
0.113
AC:
537
AN:
4770
European-Finnish (FIN)
AF:
0.113
AC:
1194
AN:
10532
Middle Eastern (MID)
AF:
0.0714
AC:
21
AN:
294
European-Non Finnish (NFE)
AF:
0.0394
AC:
2674
AN:
67944
Other (OTH)
AF:
0.0972
AC:
205
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
701
1403
2104
2806
3507
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
178
356
534
712
890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0683
Hom.:
1501
Bravo
AF:
0.120
TwinsUK
AF:
0.0345
AC:
128
ALSPAC
AF:
0.0418
AC:
161
ESP6500AA
AF:
0.234
AC:
975
ESP6500EA
AF:
0.0362
AC:
298
ExAC
AF:
0.0443
AC:
3961
Asia WGS
AF:
0.0980
AC:
341
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

TRAF3IP1-related disorder Benign:1
Oct 21, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.053
BayesDel_addAF
Benign
-0.82
T
BayesDel_noAF
Benign
-0.81
CADD
Benign
2.2
DANN
Benign
0.24
DEOGEN2
Benign
0.0048
.;T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.0012
N
LIST_S2
Benign
0.15
T;T
MetaRNN
Benign
0.0047
T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
-0.60
N;N
PhyloP100
0.66
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-0.060
N;N
REVEL
Benign
0.033
Sift
Benign
0.42
T;T
Sift4G
Benign
0.86
T;T
Polyphen
0.0
B;B
Vest4
0.026
MPC
0.11
ClinPred
0.0012
T
GERP RS
-0.82
Varity_R
0.013
gMVP
0.026
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3769110; hg19: chr2-239237751; API